¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"focal sclerosing glomerulopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sclerosing osteogenic sarcoma
    °æÈ­»ÀÀ°Á¾, °æÈ­°ñÀ°Á¾
  • sclerosing retroperitonitis
    °æÈ­Èĺ¹¸·¿°, °æÈ­¹è¸·µÚ¿°
  • sclerosing solution
    °æÈ­¾×
  • focal
    1. ±¹¼Ò-, ÃÊÁ¡- 2. º´ÅÍ-
  • focal convulsive seizure
    ÃÊÁ¡°æ·Ã¹ßÀÛ
  • focal dermal hypoplasia
    ±¹¼ÒÁøÇÇÇü¼ºÀúÇÏÁõ
  • focal distance
    ÃÊÁ¡°Å¸®
  • focal embolic glomerulonephritis
    ÃÊÁ¡»öÀüÅ丮ÄáÆÏ¿°, ÃÊÁ¡»öÀü»ç±¸Ã¼½Å¿°
  • focal epilepsy
    ÃÊÁ¡°£Áú
  • focal glomerular sclerosis
    ±¹¼ÒÅ丮±»À½Áõ, ±¹¼Ò»ç±¸Ã¼°æÈ­Áõ
  • focal glomerulonephritis
    ÃÊÁ¡Å丮ÄáÆÏ¿°, ÃÊÁ¡»ç±¸Ã¼½Å¿°
  • focal hyperkeratosis
    ±¹¼Ò°ú´Ù°¢È­Áõ
  • focal length
    ÃÊÁ¡°Å¸®, ÃÊÁ¡±æÀÌ
  • focal lesion
    ±¹¼Òº´ÅÍ
  • focal point
    ÃÊÁ¡
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • focal dermal hypoplasia
    ±¹¼ÒÁøÇÇÇü¼ºÀúÇÏÁõ
  • focal embolic glomerulonephritis
    ÃÊÁ¡»öÀüÅ丮ÄáÆÏ¿°, ÃÊÁ¡»öÀü»ç±¸Ã¼½Å¿°
  • focal glomerular sclerosis
    ±¹¼ÒÅ丮±»À½Áõ, ±¹¼Ò»ç±¸Ã¼°æÈ­Áõ
  • focal proliferative glomerulonephritis
    ÃÊÁ¡Áõ½ÄÅ丮ÄáÆÏ¿°, ÃÊÁ¡Áõ½Ä»ç±¸Ã¼½Å¿°
  • focal segmental glomerulonephritis
    ÃÊÁ¡ºÐÀýÅ丮ÄáÆÏ¿°, ÃÊÁ¡ºÐÀý»ç±¸Ã¼½Å¿°
  • focal segmental glomerulosclerosis
    (¢¡focal glomerular sclerosis) ±¹¼ÒÅ丮±»À½Áõ, ±¹¼Ò»ç±¸Ã¼°æÈ­Áõ
  • oral focal v hyperplasia
    ÀԾȱ¹¼Ò»óÇÇÁõ½Ä
  • sclerosing adenitis
    °æÈ­»ù¿°
  • sclerosing adenosis
    °æÈ­»ùÁõ
  • sclerosing agent
    °æÈ­Á¦
  • sclerosing angioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°
  • subacute sclerosing encephalitis
    ¾Æ±Þ¼º°æÈ­³ú¿°
  • sclerosing fibrosis
    °æÈ­¼¶À¯Áõ
  • sclerosing gastritis
    °æÈ­À§¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • infection, tonsillar focal
    Æíµµº´¼Ò°¨¿°
  • posterior focal line
    ÈÄÃʼ±(ý­õ¥àÊ).
  • posterior focal point
    ÈÄÃÊÁ¡(ý­õ¥ïÇ).
  • primary focal point
    Á¦ÀÏÃÊÁ¡
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • focal infection
    ±¹¼Ò°¨¿°
  • focal infection
    º´¼Ò°¨¿°
  • focal length
    ÃÊÁ¡ (õ¥ïÇ) ±æÀÌ
  • focal length
    ÃÊÁ¡°Å¸®
  • focal length
    ÃÊÁ¡ ±æÀÌ
  • focal lesion
    ÃÊÁ¡(¼º)º´º¯, ÃÊÁ¡(¼º)º´¼Ò
  • focal line
    ÃÊÁ¡¼±(õ¥ïÇàÊ).
  • focal mucinosis
    ±¹¼ÒÁ¡¾×Áõ
  • focal necrosis
    ±¹¼Ò±«»ç
  • focal nephritis
    ÃÊÁ¡¼º ½Å¿°.
  • focal plane
    Ãʸé
  • focal point
    ÃÊÁ¡
  • focal segmental glomerulonephritis
    ÃÊÁ¡¼º ºÐÀý(¼º) »ç±¸Ã¼½Å¿°
  • focal segmental glomerulosclerosis; FSGS
    ±¹¼Ò¼ººÐÀý¼º»ç±¸Ã¼°æÈ­(Áõ)
  • focal spot
    ±¹¼Ò ÃÊÁ¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PSC patient services coordination; Porter-Silber chromogen; posterior subcapsular cataract; primary scle...
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
SL sarcolemma; sclerosing leukoencephalopathy; secondary leukemia; segment length; sensation level; sen...
SSP Sanarelli-Shwartzman phenomenon; subacute sclerosing panencephalitis; slice sensitivity profile; sub...
SSPE subacute sclerosing panencephalitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SC sclerosing cholangitis
FAK Focal Adhesion Kinase
FDH Focal Dermal Hypoplasia
FNH Focal Nodular Hyperplasia
FSGS Focal Segmental Glomerulosclerosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • focal epithelial
    ±¹¼Ò¼º »óÇÇ
  • focal glomerulonephritis
    ÃÊÁ¡¼º »ç±¸Ã¼ ½Å¿°
  • focal infection
    ÃÊÁ¡ °¨¿°
  • focal length
    ÃÊÁ¡ °Å¸®
    Áý±¤ ·»Áî·ÎºÎÅÍ ÃÖ´ë ÃÊÁ¡ À§Ä¡±îÁöÀÇ °Å¸®.
  • focal myelitis
    ¼Ò»ó ô¼ö¿°
  • focal nodular hyperplasia
    ÃÊÁ¡¼º °áÀý¼º °úÁõ½Ä
    À§ Á¾¾çÀ¸·Î ºÐ·ùµÇ´Â °£ÀÇ °áÀý¼º º´º¯ÀÇ ÇÑ À¯ÇüÀ¸·Î¼­ °ú¿ÀÁ¾¼º ¹ßÀ° °á¼Õ¿¡ ±âÀÎÇÑ ´ÜÀÏ Á¾±«¼º º´º¯À¸·Î ÇØ¼®µÇ°í ÀÖ´Ù. ÀÌ´Â ÁÖ·Î ÇǸ·ÇÏ¿¡ Àß »ý±â°í Å©±â´Â ¼ö cm ³»¿ÜÀÌ¸ç ¾ãÀº ÆÐ¸·¿¡ ÀÇÇÏ¿© ÁÖº¯ °£ Á¶Á÷À¸·ÎºÎÅÍ Àß ±¸ºÐµÈ´Ù. Àý´Ü¸é¿¡¼­ Á¾±«ÀÇ °¡¿îµ¥¿¡ º° ¸ð¾çÀÇ ¹ÝÈç
  • focal oral mucitis
    ±¹¼Ò¼º ±¸°­ Á¡¾×Áõ
  • focal plane
    ÃÊÁ¡ ´Ü¸é
  • focal point
    ÃÊÁ¡
    ºûÀÌ Áý±¤ ·»Á ÅëÇØ Áö³ª°¥ ¶§ ±¤¼ÓÀÌ ÃÖ´ëÇÑ ³óÃàµÈ À§Ä¡.
  • focal proliferative glomerulonephritis
    ÃÊÁ¡¼º Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°
  • focal seizure
    ±¹¼Ò °£Áú
  • focal spot
    ÃÐÁ¡
  • focal trough
    »óÃþ
  • posterior focal point
    ÈÄ ÃÊÁ¡
  • progressive focal neurologic disturbance
    ÁøÇ༺ ±¹¼ÒÀû ½Å°æÇÐÀû Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
sclerosing solutions Chemical agents injected into veins to cause localised thrombosis and eventual fibrosis and obliteration of the vessels. They are used in the treatment of varicose veins, haemorrhoids, gastric and oesophageal varices, and peptic ulcer haemorrhage.
(12 Dec 1998)
sclerosing therapy A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver.
(27 Sep 1997)
subacute sclerosing leukoencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
subacute sclerosing panencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
anterior focal point The point where parallel rays from the retina are focused.
(05 Mar 2000)
back focal length <microscopy> As measured on the principal axis, from the second lens vertex to the back focal point of the lens. It is not the equivalent of the focal length.
(05 Aug 1998)
back focal plane <microscopy> The plane, normal to the lens axis, situated at the back focus of a lens.
(05 Aug 1998)
Berger's focal glomerulonephritis Glomerulonephritis affecting a small proportion of renal glomeruli which commonly presents with haematuria and may be associated with acute upper respiratory infection in young males, not usually due to streptococci; associated with IgA deposits in the glomerular mesangium and may also be associated with systemic disease, as in Henoch-Schonlein purpura.
Synonym: Berger's disease, Berger's focal glomerulonephritis, focal nephritis, IgA nephropathy.
(05 Mar 2000)
glomerulosclerosis, focal Glomerular disease characterised by focal and segmental areas of glomerular sclerosis, usually commencing in the juxtamedullary glomeruli and gradually spreading to involve other parts of the kidney, with eventual kidney failure.
(12 Dec 1998)
plane, focal <microscopy> A plane through the focal point perpendicular to the principle axis of a lens or mirror.
(05 Aug 1998)
positive focal length <microscopy> Any lens which converges parallel rays to a focus at the back of the lens is a positive lens and has a positive focal length. The focal length is measured from the second principal point of the lens to the point on the lens axis where the rays from an infinitely distant point are brought to focus.
See: negative focal length.
(05 Aug 1998)
posterior focal point The point of a compound optical system where parallel rays entering the system are focused.
(05 Mar 2000)
cutaneous focal mucinosis Flesh-coloured papules of the skin, composed of homogenous mucinous material with scattered fibroblasts.
(05 Mar 2000)
proximal femoral focal deficiency A congenital defect in which variable portions of the upper end of the femur are reduced or absent.
(05 Mar 2000)
negative focal length <physics> The focal length of a negative lens. Parallel rays impinging on a negative lens can be traced to a virtual focus which exists on the same side of the lens as the impinging rays. The distance from the second principal point of the lens to this second focal point is measured on the same side of the lens as is the object.
See: negative lens, focal length.
(05 Aug 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á